Kim Arvid Nielsen, CEO

Kim Arvid Nielsen is a physician and Executive Master of Business Administration with extensive experience in business development, investor relations and drug development. He has previously held a number of senior roles in smaller life science enterprises as well as global pharmaceutical companies, including Cytovac, Scandion Oncology, Serendex, Bayer, Pharmion, Ferrosan and Serono Nordic

Kim Arvid Nielsen, CEO Follicum

Shares in the company:
No shares

Nielsen’s other assignments:
Brain Plus: Board Member

Jan Alenfall, CSO

Jan Alenfall holds a PhD and has over 20 years’ experience from pharmaceutical research and development, for example from research regarding new treatment for immunological diseases and cancer. Alenfall was Head of Pre-clinical and Clinical Development at Bioglan. He has also been Head of Research at Probi AB. Alenfall has solid experience within research, product development, pre-clinical and clinical trials and also in commercial collaborations. In 2006 he was appointed CEO at DermaGen AB. Alenfall has been the author and co-author of 17 publications in scientific journals and has six patent applications.

Jan Alenfall, CEO Follicum

Shares in the company:
Alenfall owns 100 % of Callipa AB, which owns 338 633 shares in Follicum AB.

Alenfall’s other assignments:
Callipa AB: Board Member, CEO

Maria Ekblad, R & D Director

Maria Ekblad has a Masters in Chemical Engineering and more than 20 years’ experience in the pharmaceutical industry. Among these are research and development of new drugs for auto-immune diseases and cancer. In several assignments Maria was in charge of pre-clinical development at Active Biotech as well as their contract research services.

Maria Ekblad, R&D Director Follicum

Shares in the company:
Ekblad owns 13 330 shares in Follicum AB.

Jonas Edelswärd, CFO

Jonas Edelswärd holds a MSc in Economics and is involved in financing of companies in development phase. Edelswärd has previously been the CFO of Zaplox when Zaplox was introduced at First North. He has more than 25 years’ experience from various positions from high-tech startups and growth companies evolving from the innovation environments of Lund University, Malmö University, Ideon Innovation and Malmö Incubator (MINC). He has also held senior positions in more mature companies, such as CEO for the privately owned investment company AB Axel Granlund. Edelswärd has extensive experience from evaluating small and mid-sized companies in various development phases, not least from his role as business development manager and CEO at Teknopol AB. He has previously also worked with company financing in his role as CFO at Almi Företagspartner Skåne. Further, Edelswärd is a certified board member from the Swedish Academy of Board Directors and has been and is active in several boards of directors.


Shares in the company:
No shares

Edelswärd’s other assignments:

  • Zaplox AB: Chairman of the Board
  • Galenica AB: Board Member
  • Pragati AB: Board Member
  • Humanus Utbildning Syd AB: Board Member
  • Galerie Leger AB: Deputy Board Member